Check out your Company Bowl for anonymous work chats.
Exogen Summit 2024
Customer service recognition day 2024
In honor of the Olympics, we’re excited to announce our very own Bioventus Olympics! We had an absolute blast! 🎉 Everyone came out to join the fun and competitive games like cornhole, giant Connect 4, and giant Jenga. Congratulations to our Gold, Silver and Bronze Olympian winners!
LIPUS fracture repair
Our community Partners......
Internship Spotlight
Discover the lasting benefits of Durolane.
Robert Claypoole Named CEO Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth Bioventus Inc a global leader in innovations for active healing, announced that its Board of Directors has appointed Robert (Rob) Claypoole as Bioventus’ President and Chief Executive Officer and a member of its Board of Directors, effective January 10, 2024. Mr. Claypoole succeeds Mr. Anthony Bihl who has served as interim CEO and a director on the Board since April 2023. Mr. Claypoole brings more than 20 years of global commercial leadership experience in the medical device industry, and a history of success in accelerating revenue growth and enhancing operational profitability. He most recently served as Executive Vice President at Mölnlycke Health Care AB, where he led Mölnlycke’s $1.2 billion global Wound Care business. Mr. Claypoole previously held senior positions at Medtronic, Covidien and Johnson & Johnson. Throughout his career, he has developed extensive expertise in transforming global medical device businesses to accelerate innovation, drive organizational efficiencies, and enhance go-to-market strategies to deliver above market revenue growth.
